Study S003198

Investigation of the Effect of NNC0487-0111 on Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Females of Non-childbearing Potential

ClinicalTrials.gov record

Registration

Registration: NCT06461039
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 43
Start: 2024-06-14
Primary completion: 2025-03-16
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:NNC0487-0111 A; DRUG:NNC0487-0111 C; DRUG:Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC); DRUG:Acetaminophen - 500 mg/15 ml
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1300-3685

Registered primary outcomes

The area under the ethinylestradiol plasma concentration time curve at steady state [Day 8 and Day 193]
The area under the levonorgestrel plasma concentration time curve at steady state [Day 8 and Day 193]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.